Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

203.50p
   
  • Change Today:
      4.50p
  • 52 Week High: 254.00p
  • 52 Week Low: 179.20p
  • Currency: UK Pounds
  • Shares Issued: 217.78m
  • Volume: 532,493
  • Market Cap: £443.19m
  • RiskGrade: 156
  • Beta: 0.87

AMS Overview

We are a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on value for our customers and quality outcomes for patients.
Competitors: Convatec Group, Consort Medical
Registrars: Capita Registrars

Key Personnel

CEO: A Christopher (Chris) Meredith
CFO: Eddie Johnson
Chairman: Liz Shanahan
Independent Non-Executive Director: Douglas Le Fort
Senior Independent Non-Executive Director: Grahame Cook
Non-Executive Dir:

Contact Details

Address: Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, United Kingdom, CW7 3RT
Phone: +44 (0) 1606 863500
Fax: +44 (0) 1606 863600
Website: http://www.admedsol.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
ISIN: GB0004536594

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 203.50p
Change Today 4.50p
% Change 2.26 %
52 Week High 254.00p
52 Week Low 179.20p
Volume 532,493
Shares Issued 217.78m
Market Cap £443.19m
Beta 0.87
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.18% below the market average66.18% below the market average66.18% below the market average66.18% below the market average66.18% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
27.71% below the market average27.71% below the market average27.71% below the market average27.71% below the market average27.71% below the market average
13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average
Income
84.55% below the market average84.55% below the market average84.55% below the market average84.55% below the market average84.55% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
30.34% below the market average30.34% below the market average30.34% below the market average30.34% below the market average30.34% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Interim Final
Ex-Div 26-Sep-24 30-May-24
Paid 25-Oct-24 21-Jun-24
Amount 0.77p 1.66p

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 18 @ 203.50p
16:26 81 @ 204.00p
16:26 164 @ 204.00p
16:26 1,100 @ 204.00p
16:26 2,000 @ 204.00p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page